FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890165727> ?p ?o ?g. }

• W2890165727 endingPage "1045" @default.
• W2890165727 startingPage "1045" @default.
• W2890165727 abstract "<h3>Importance</h3> An alternative option to maternal vaccination to prevent severe pertussis in infants is vaccination at birth. Data are needed on the immunogenicity and safety of a birth dose of monovalent acellular pertussis (aP) vaccine. <h3>Objective</h3> To compare IgG antibody responses to vaccine antigens at 6, 10, 24, and 32 weeks of age between newborn infants receiving the aP vaccine and hepatitis B vaccine (HBV) or HBV alone. <h3>Design, Setting, and Participants</h3> A randomized clinical trial was conducted at 4 sites in Australia (Sydney, Melbourne, Adelaide, and Perth) between June 11, 2010, and March 14, 2013, among 440 healthy term (>36 weeks’ gestation) infants aged less than 5 days at recruitment. Statistical analysis was performed from March 1, 2015, to June 2, 2016. <h3>Intervention</h3> Newborns received HBV and, after stratification by maternal receipt of adult-formulated aP-containing vaccine (tetanus toxoid, reduced diphtheria toxoid, and pertussis antigen content [Tdap]) prior to pregnancy, were block randomized to receive the aP vaccine (without diphtheria or tetanus) within 5 days of birth or not. At 6, 16, and 24 weeks, infants received a hexavalent vaccine with pediatric-formulated diphtheria, tetanus and pertussis antigens (DTaP),<i>Haemophilus influenzae</i>type b (Hib), HBV, and polio vaccine, as well as the 10-valent pneumococcal conjugate vaccine. <h3>Main Outcomes and Measures</h3> Detectable (>5 enzyme-linked immunosorbent assay units per milliliter) and geometric mean concentrations of IgG antibody to pertussis toxin (PT), pertactin, and filamentous hemagglutinin at 6, 10, and 24 weeks stratified by maternal Tdap history, and antibody at 32 weeks to HBV, Hib, polio, diphtheria, tetanus, and pneumococcal serotypes. The primary outcome was detectable IgG to both PT and pertactin at 10 weeks. <h3>Results</h3> A total of 440 infants (207 girls and 233 boys; median gestation, 39.2 weeks) were randomized to receive the aP vaccine plus HBV (n = 221) or HBV only (control group; n = 219). At 10 weeks, 192 of 206 infants who received the aP vaccine (93.2%) had detectable antibodies to both PT and pertactin vs 98 of 193 infants in the control group (50.8%) (<i>P</i> < .001), with the geometric mean concentration for PT IgG 4-fold higher among the group that received the aP vaccine. At age 32 weeks, all infants (n = 181 with sera available for testing) who received the aP vaccine at birth had detectable PT IgG and significantly lower IgG geometric mean concentrations for Hib, hepatitis B, diphtheria, and tetanus antibodies. Local and systemic adverse events were similar between both groups at all time points. <h3>Conclusions and Relevance</h3> The monovalent aP vaccine is immunogenic and safe in neonates and, if licensed and available, would be valuable for newborns whose mothers did not receive the Tdap vaccine during pregnancy. <h3>Trial Registration</h3> http://anzctr.org.auIdentifier:ACTRN12609000905268" @default.
• W2890165727 created "2018-09-27" @default.
• W2890165727 creator A5000535781 @default.
• W2890165727 creator A5005901241 @default.
• W2890165727 creator A5012681032 @default.
• W2890165727 creator A5030667842 @default.
• W2890165727 creator A5038228333 @default.
• W2890165727 creator A5057450435 @default.
• W2890165727 creator A5076576316 @default.
• W2890165727 date "2018-11-01" @default.
• W2890165727 modified "2023-09-27" @default.
• W2890165727 title "Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth" @default.
• W2890165727 cites W1653228618 @default.
• W2890165727 cites W1673458349 @default.
• W2890165727 cites W1969990167 @default.
• W2890165727 cites W1979100651 @default.
• W2890165727 cites W1980840966 @default.
• W2890165727 cites W1983797500 @default.
• W2890165727 cites W2003864456 @default.
• W2890165727 cites W2039094592 @default.
• W2890165727 cites W2050340704 @default.
• W2890165727 cites W2058949096 @default.
• W2890165727 cites W2064764062 @default.
• W2890165727 cites W2080690130 @default.
• W2890165727 cites W2082572598 @default.
• W2890165727 cites W2088030848 @default.
• W2890165727 cites W2119949211 @default.
• W2890165727 cites W2128532234 @default.
• W2890165727 cites W2132840565 @default.
• W2890165727 cites W2136298756 @default.
• W2890165727 cites W2137243968 @default.
• W2890165727 cites W2152139919 @default.
• W2890165727 cites W2183670502 @default.
• W2890165727 cites W2269112519 @default.
• W2890165727 cites W2345032774 @default.
• W2890165727 cites W2550291580 @default.
• W2890165727 cites W2554060857 @default.
• W2890165727 cites W2599785681 @default.
• W2890165727 cites W2601429733 @default.
• W2890165727 cites W2611706553 @default.
• W2890165727 cites W2615302290 @default.
• W2890165727 cites W2759536015 @default.
• W2890165727 cites W2766654418 @default.
• W2890165727 cites W2784224170 @default.
• W2890165727 doi "https://doi.org/10.1001/jamapediatrics.2018.2349" @default.
• W2890165727 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6248137" @default.
• W2890165727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30208475" @default.
• W2890165727 hasPublicationYear "2018" @default.
• W2890165727 type Work @default.
• W2890165727 sameAs 2890165727 @default.
• W2890165727 citedByCount "33" @default.
• W2890165727 countsByYear W28901657272018 @default.
• W2890165727 countsByYear W28901657272019 @default.
• W2890165727 countsByYear W28901657272020 @default.
• W2890165727 countsByYear W28901657272021 @default.
• W2890165727 countsByYear W28901657272022 @default.
• W2890165727 countsByYear W28901657272023 @default.
• W2890165727 crossrefType "journal-article" @default.
• W2890165727 hasAuthorship W2890165727A5000535781 @default.
• W2890165727 hasAuthorship W2890165727A5005901241 @default.
• W2890165727 hasAuthorship W2890165727A5012681032 @default.
• W2890165727 hasAuthorship W2890165727A5030667842 @default.
• W2890165727 hasAuthorship W2890165727A5038228333 @default.
• W2890165727 hasAuthorship W2890165727A5057450435 @default.
• W2890165727 hasAuthorship W2890165727A5076576316 @default.
• W2890165727 hasBestOaLocation W28901657271 @default.
• W2890165727 hasConcept C126322002 @default.
• W2890165727 hasConcept C159654299 @default.
• W2890165727 hasConcept C170493617 @default.
• W2890165727 hasConcept C187212893 @default.
• W2890165727 hasConcept C196419574 @default.
• W2890165727 hasConcept C203014093 @default.
• W2890165727 hasConcept C22070199 @default.
• W2890165727 hasConcept C2777351567 @default.
• W2890165727 hasConcept C2777382497 @default.
• W2890165727 hasConcept C2778866548 @default.
• W2890165727 hasConcept C2779634000 @default.
• W2890165727 hasConcept C2779841045 @default.
• W2890165727 hasConcept C2780572238 @default.
• W2890165727 hasConcept C2780801004 @default.
• W2890165727 hasConcept C2781253189 @default.
• W2890165727 hasConcept C49773422 @default.
• W2890165727 hasConcept C501593827 @default.
• W2890165727 hasConcept C71924100 @default.
• W2890165727 hasConcept C80631254 @default.
• W2890165727 hasConcept C8439097 @default.
• W2890165727 hasConcept C86803240 @default.
• W2890165727 hasConcept C89423630 @default.
• W2890165727 hasConceptScore W2890165727C126322002 @default.
• W2890165727 hasConceptScore W2890165727C159654299 @default.
• W2890165727 hasConceptScore W2890165727C170493617 @default.
• W2890165727 hasConceptScore W2890165727C187212893 @default.
• W2890165727 hasConceptScore W2890165727C196419574 @default.
• W2890165727 hasConceptScore W2890165727C203014093 @default.
• W2890165727 hasConceptScore W2890165727C22070199 @default.
• W2890165727 hasConceptScore W2890165727C2777351567 @default.
• W2890165727 hasConceptScore W2890165727C2777382497 @default.
• W2890165727 hasConceptScore W2890165727C2778866548 @default.

• next